Skip to content
PEPTIDESUNCENSORED

The atlas

23 compounds. Every claim graded.

Filter by goal, cadence, route and evidence. Every card shows its evidence grade and regulatory status before anything else.

Showing 23 of 23

  • Repair

    Body Protection Compound-157 · PL 14736

    BPC-157

    A 15-amino-acid gastric fragment. Heals rats impressively. Completed human efficacy trials: zero.

    DailySC · Oral
    Open dossier

  • Metabolic

    Ozempic · Wegovy

    Semaglutide

    The GLP-1 drug in Ozempic and Wegovy. 14.9% weight loss in STEP 1, fewer heart attacks in SELECT. A prescription drug.

    WeeklySC · Oral
    Open dossier

  • Metabolic

    Mounjaro · Zepbound

    Tirzepatide

    Lilly's GIP/GLP-1 dual agonist (Mounjaro, Zepbound). 20.9% weight loss in SURMOUNT-1. Beat semaglutide head-to-head.

    WeeklySC
    Open dossier

  • Metabolic

    LY3437943 · Reta

    Retatrutide

    Lilly's GLP-1/GIP/glucagon triple agonist. About 28% weight loss at 80 weeks in Phase 3. Still not approved.

    WeeklySC
    Open dossier

  • Repair

    Thymosin beta-4 fragment · Ac-LKKTETQ

    TB-500

    A 7-amino-acid slice of thymosin beta-4. The human trials used the full protein. The fragment has almost none of its own.

    2×/wkSC · IM
    Open dossier

  • GH-axis

    CJC-1295 with DAC · CJC-1295 no DAC

    CJC-1295

    Two different drugs under one name: a week-long albumin-bound GHRH analog and a short-acting one. Small PK studies, no efficacy trials.

    DailySC
    Open dossier

  • GH-axis

    Ipamorelin acetate · Ipa

    Ipamorelin

    Selective ghrelin-receptor agonist. Clean GH pulse in rats and pigs. Its one human efficacy trial did not beat placebo.

    DailySC
    Open dossier

  • Skin

    Copper peptide · Copper tripeptide-1

    GHK-Cu

    Copper-binding tripeptide found in blood. Small topical skin studies, mixed results. Injectable human data: none.

    DailyTopical · SC
    Open dossier

  • Longevity

    Nicotinamide adenine dinucleotide · NAD

    NAD+

    A coenzyme, not a peptide. Oral precursors raise blood NAD in trials, with modest effects. IV drips have almost no trial data.

    DailyOral · SC · IV
    Open dossier

  • Sexual

    Bremelanotide · Vyleesi

    PT-141

    FDA-approved as Vyleesi for low desire in premenopausal women. Modest effect, nausea in 40%. Not approved for men.

    On demandSC
    Open dossier

  • Skin

    MT-II · MT2

    Melanotan II

    Unapproved tanning and libido peptide. It tans, and also darkens moles, causes nausea and erections. Regulators keep warning.

    DailySC · Nasal
    Open dossier

  • Longevity

    Mitochondrial open reading frame of the 12S rRNA-c · MOTSc

    MOTS-c

    A 16-aa peptide encoded in mitochondrial DNA. Acts like an exercise signal in mice. Completed human trials of MOTS-c: zero.

    2×/wkSC
    Open dossier

  • GH-axis

    Egrifta · Egrifta SV

    Tesamorelin

    FDA-approved GHRH analog for HIV-associated belly fat. Real RCTs for that. The physique use is extrapolation.

    DailySC
    Open dossier

  • GH-axis

    Geref · GHRH (1-29)

    Sermorelin

    GHRH(1-29). FDA-approved as Geref until 2008, dropped for business reasons. Widely compounded now. Adult anti-ageing trials: tiny.

    DailySC
    Open dossier

  • Longevity

    Epithalon · Epithalone

    Epitalon

    Four-amino-acid pineal peptide from one Russian lab. Telomere claims come from cell cultures. Independent human trials: none.

    CourseSC
    Open dossier

  • Metabolic

    AOD9604 · Tyr-hGH 177–191

    AOD-9604

    A growth hormone tail fragment developed as an obesity drug. It failed its 536-person trial in 2007. Still sold for fat loss.

    DailySC · Oral
    Open dossier

  • Immune

    Thymalfasin · Zadaxin

    Thymosin alpha-1

    Thymic peptide approved in dozens of countries, not the US. Real RCTs. The largest, in sepsis, found no mortality benefit.

    2×/wkSC
    Open dossier

  • Longevity

    Elamipretide · Forzinity

    SS-31

    Mitochondria-targeted tetrapeptide. FDA-approved (as Forzinity) for one rare disease. The longevity use is extrapolation.

    DailySC
    Open dossier

  • Cognitive

    Семакс · ACTH(4-10) analog

    Semax

    Russian-approved ACTH-fragment nasal drop for stroke and cognition. Rat BDNF data, small Russian studies, no Western trials.

    CourseNasal
    Open dossier

  • Cognitive

    Селанк · Tuftsin analog

    Selank

    Russian-approved anti-anxiety nasal peptide built on tuftsin. Small Russian studies, no placebo-controlled Western trials.

    CourseNasal
    Open dossier

  • Metabolic

    5-amino-1-methylquinolinium · 5A1MQ

    5-Amino-1MQ

    Not a peptide: a small molecule that blocks the enzyme NNMT. Shrank fat in obese mice. Human trials: none.

    DailyOral
    Open dossier

  • Repair

    Lys-Pro-Val · α-MSH (11–13)

    KPV

    Three amino acids from the tail of alpha-MSH. Calms colitis in mice. Completed human efficacy trials: none we could find.

    DailyOral · SC
    Open dossier

  • Cognitive

    EDR peptide · Glu-Asp-Arg

    Pinealon

    Russian "bioregulator" tripeptide aimed at the brain. Cell and rat data from one research school. Human data: very thin.

    CourseOral · SC
    Open dossier

Evidence grades describe the quality of human evidence for the popular use. They are not safety ratings and not recommendations. How we grade